Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reiji Yoshimura

Showing results (71-80 of 297) with videos related to

Pageof 30
Sort By:
Cureus|February 12, 2024
Oromandibular Dystonia After Low-Dose Olanzapine Treatment in a Patient With Marchiafava-Bignami Disease With Demyelinating Lesions in the Corpus Callosum: A Case ReportNagiho Tsukada, Naomichi Okamoto, Yuki Konishi, et al.
Journal of Clinical Psychopharmacology|August 11, 2016
A Case of Mutism in Noncatatonic Schizophrenia Responding to Small Dose of Fluvoxamine Addition to ClozapineHirofumi Hirakawa, Takeshi Terao, Toshiko Tanaka, et al.
Lancet (London, England)|December 14, 2002
Effect of latitude on suicide rates in JapanTakeshi Terao, Shuji Soeda, Reiji Yoshimura, et al.
Pharmacopsychiatry|January 31, 2020
Blonanserin patch vs. Other Antipsychotics for Acute Schizophrenia: A Systematic Review of Double-blind, Randomized, Placebo-controlled, Phase 3 Trials in JapanTaro Kishi, Reiji Yoshimura, Yuki Matsuda, et al.
Frontiers in Psychiatry|March 16, 2018
Serum Brain-Derived Neurotrophic Factor, and Plasma Catecholamine Metabolites in People with Major Depression: Preliminary Cross-Sectional StudyReiji Yoshimura, Taro Kishi, Kiyokazu Atake, et al.
Frontiers in Behavioral Neuroscience|December 25, 2014
Relationships between brain-derived neurotrophic factor, clinical symptoms, and decision-making in chronic schizophrenia: data from the Iowa Gambling TaskHikaru Hori, Reiji Yoshimura, Asuka Katsuki, et al.
Psychiatria Danubina|June 30, 2022
Differences in the Disease Severity and Background Characteristics of Patients with Suicide Attempts Due to Overdose According to the Time of DayTatsuro Hirashima, Naomichi Okamoto, Atsuko Ikenouchi, et al.
BMC Psychiatry|October 27, 2023
Agoraphobia and panic attacks complicated by primary aldosteronism improved by treatment with eplerenone: a case reportReoto Kijima, Hirofumi Tesen, Ryohei Igata, et al.
Psychiatry and Clinical Neurosciences|July 6, 2007
Therapeutic drug monitoring of plasma fluvoxamine levels for treating bulimia nervosaAtsuko Ikenouchi-Sugita, Reiji Yoshimura, Hikaru Hori, et al.
General Hospital Psychiatry|June 19, 2012
Aripiprazole improves various cognitive and behavioral impairments after traumatic brain injury: a case reportWakako Umene-Nakano, Reiji Yoshimura, Tatsuya Okamoto, et al.
Pageof 30

Showing results (71-80 of 297) with videos related to

Sort By:
Pageof 30
Cureus|February 12, 2024
Oromandibular Dystonia After Low-Dose Olanzapine Treatment in a Patient With Marchiafava-Bignami Disease With Demyelinating Lesions in the Corpus Callosum: A Case ReportNagiho Tsukada, Naomichi Okamoto, Yuki Konishi, et al.
Journal of Clinical Psychopharmacology|August 11, 2016
A Case of Mutism in Noncatatonic Schizophrenia Responding to Small Dose of Fluvoxamine Addition to ClozapineHirofumi Hirakawa, Takeshi Terao, Toshiko Tanaka, et al.
Lancet (London, England)|December 14, 2002
Effect of latitude on suicide rates in JapanTakeshi Terao, Shuji Soeda, Reiji Yoshimura, et al.
Pharmacopsychiatry|January 31, 2020
Blonanserin patch vs. Other Antipsychotics for Acute Schizophrenia: A Systematic Review of Double-blind, Randomized, Placebo-controlled, Phase 3 Trials in JapanTaro Kishi, Reiji Yoshimura, Yuki Matsuda, et al.
Frontiers in Psychiatry|March 16, 2018
Serum Brain-Derived Neurotrophic Factor, and Plasma Catecholamine Metabolites in People with Major Depression: Preliminary Cross-Sectional StudyReiji Yoshimura, Taro Kishi, Kiyokazu Atake, et al.
Frontiers in Behavioral Neuroscience|December 25, 2014
Relationships between brain-derived neurotrophic factor, clinical symptoms, and decision-making in chronic schizophrenia: data from the Iowa Gambling TaskHikaru Hori, Reiji Yoshimura, Asuka Katsuki, et al.
Psychiatria Danubina|June 30, 2022
Differences in the Disease Severity and Background Characteristics of Patients with Suicide Attempts Due to Overdose According to the Time of DayTatsuro Hirashima, Naomichi Okamoto, Atsuko Ikenouchi, et al.
BMC Psychiatry|October 27, 2023
Agoraphobia and panic attacks complicated by primary aldosteronism improved by treatment with eplerenone: a case reportReoto Kijima, Hirofumi Tesen, Ryohei Igata, et al.
Psychiatry and Clinical Neurosciences|July 6, 2007
Therapeutic drug monitoring of plasma fluvoxamine levels for treating bulimia nervosaAtsuko Ikenouchi-Sugita, Reiji Yoshimura, Hikaru Hori, et al.
General Hospital Psychiatry|June 19, 2012
Aripiprazole improves various cognitive and behavioral impairments after traumatic brain injury: a case reportWakako Umene-Nakano, Reiji Yoshimura, Tatsuya Okamoto, et al.
Pageof 30